XML 12 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Series A redeemable convertible preferred stock [Member]
Preferred Stock [Member]
Series B-1 Redeemable Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series B-2 Redeemable Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series C redeemable convertible preferred stock [Member]
Preferred Stock [Member]
Series D redeemable convertible preferred stock [Member]
Preferred Stock [Member]
Beginning balance (in shares) at Dec. 31, 2022           11,250,000 16,285,156 25,065,538 17,905,288 29,285,356
Beginning balance at Dec. 31, 2022           $ 8,643 $ 12,611 $ 28,860 $ 42,100 $ 79,730
Beginning balance (in shares) at Dec. 31, 2022   2,915,757                
Beginning balance at Dec. 31, 2022 $ (101,467) $ 3 $ 20,501 $ (413) $ (121,558)          
Accretion of redeemable convertible preferred stock issuance costs                   $ 20
Accretion of redeemable convertible preferred stock issuance costs (20)   (20)              
Moffitt performance based common stock award (in shares)   91,721                
Exercise of stock options (in shares)   20,658                
Exercise of stock options 83   83              
Stock-based compensation expense 992   992              
Unrealized gain (loss) on available-for-sale debt securities 121     121            
Net Income (Loss) 68       68          
Ending balance (in shares) at Mar. 31, 2023           11,250,000 16,285,156 25,065,538 17,905,288 29,285,356
Ending balance at Mar. 31, 2023           $ 8,643 $ 12,611 $ 28,860 $ 42,100 $ 79,750
Ending balance (in shares) at Mar. 31, 2023   3,028,136                
Ending balance at Mar. 31, 2023 (100,223) $ 3 21,556 (292) (121,490)          
Beginning balance (in shares) at Dec. 31, 2022           11,250,000 16,285,156 25,065,538 17,905,288 29,285,356
Beginning balance at Dec. 31, 2022           $ 8,643 $ 12,611 $ 28,860 $ 42,100 $ 79,730
Beginning balance (in shares) at Dec. 31, 2022   2,915,757                
Beginning balance at Dec. 31, 2022 $ (101,467) $ 3 20,501 (413) (121,558)          
Exercise of stock options (in shares) 21,784                  
Unrealized gain (loss) on available-for-sale debt securities $ 180                  
Net Income (Loss) (21,431)                  
Ending balance (in shares) at Jun. 30, 2023           11,250,000 16,285,156 25,065,538 17,905,288 29,285,356
Ending balance at Jun. 30, 2023           $ 8,643 $ 12,611 $ 28,860 $ 42,100 $ 79,769
Ending balance (in shares) at Jun. 30, 2023   3,029,258                
Ending balance at Jun. 30, 2023 (120,605) $ 3 22,614 (233) (142,989)          
Beginning balance (in shares) at Mar. 31, 2023           11,250,000 16,285,156 25,065,538 17,905,288 29,285,356
Beginning balance at Mar. 31, 2023           $ 8,643 $ 12,611 $ 28,860 $ 42,100 $ 79,750
Beginning balance (in shares) at Mar. 31, 2023   3,028,136                
Beginning balance at Mar. 31, 2023 (100,223) $ 3 21,556 (292) (121,490)          
Accretion of redeemable convertible preferred stock issuance costs                   $ 19
Accretion of redeemable convertible preferred stock issuance costs (19)   (19)              
Exercise of stock options (in shares)   1,122                
Exercise of stock options 3   3              
Stock-based compensation expense 1,074   1,074              
Unrealized gain (loss) on available-for-sale debt securities 59     59            
Net Income (Loss) (21,499)       (21,499)          
Ending balance (in shares) at Jun. 30, 2023           11,250,000 16,285,156 25,065,538 17,905,288 29,285,356
Ending balance at Jun. 30, 2023           $ 8,643 $ 12,611 $ 28,860 $ 42,100 $ 79,769
Ending balance (in shares) at Jun. 30, 2023   3,029,258                
Ending balance at Jun. 30, 2023 $ (120,605) $ 3 22,614 (233) (142,989)          
Beginning balance (in shares) at Dec. 31, 2023 23,099,335 23,099,335                
Beginning balance at Dec. 31, 2023 $ 98,667 $ 23 275,521 (119) (176,758)          
Exercise of stock options (in shares)   29,119                
Exercise of stock options 44   44              
Stock-based compensation expense 1,046   1,046              
Unrealized gain (loss) on available-for-sale debt securities (117)     (117)            
Net Income (Loss) (19,629)       (19,629)          
Ending balance (in shares) at Mar. 31, 2024   23,128,454                
Ending balance at Mar. 31, 2024 $ 80,011 $ 23 276,611 (236) (196,387)          
Beginning balance (in shares) at Dec. 31, 2023 23,099,335 23,099,335                
Beginning balance at Dec. 31, 2023 $ 98,667 $ 23 275,521 (119) (176,758)          
Exercise of stock options (in shares) 29,119                  
Unrealized gain (loss) on available-for-sale debt securities $ (107)                  
Net Income (Loss) $ (40,933)                  
Ending balance (in shares) at Jun. 30, 2024 23,128,454 23,128,454                
Ending balance at Jun. 30, 2024 $ 59,736 $ 23 277,630 (226) (217,691)          
Beginning balance (in shares) at Mar. 31, 2024   23,128,454                
Beginning balance at Mar. 31, 2024 80,011 $ 23 276,611 (236) (196,387)          
Stock-based compensation expense 1,019   1,019              
Unrealized gain (loss) on available-for-sale debt securities 10     10            
Net Income (Loss) $ (21,304)       (21,304)          
Ending balance (in shares) at Jun. 30, 2024 23,128,454 23,128,454                
Ending balance at Jun. 30, 2024 $ 59,736 $ 23 $ 277,630 $ (226) $ (217,691)